MedPath

Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study

Not Applicable
Completed
Conditions
Diabetes Mellitus
Registration Number
NCT02061579
Lead Sponsor
Stanford University
Brief Summary

The Initiate and Maintain Physical Activity in Clinics (IMPACT) study will determine the optimal and feasible level of frequency of structured contact needed in a clinical setting for adult patients with Type 2 Diabetes Mellitus to initiate and maintain physical activity recommendations long-term.

Detailed Description

The IMPACT Study will compare the health outcomes and lifestyle habits amongst the three groups of study participants. Study participants will be randomized into three exercise group. Group 1 will participate in instructor-led exercise training sessions 1 time per week, for 24 weeks (approximately 6 months). Group 2 will participate in instructor-led exercise training sessions 3 times per week, for 24 weeks (approximately 6 months). Group 3 will not attend any instructor-led exercise training sessions. All groups will be encouraged to see their usual providers for routine healthcare, and continue their usual medication regimen.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
354
Inclusion Criteria
  • Recent hemoglobin A1c result between 6.5 and 13.0%
  • Diagnosed with Type 2 Diabetes Mellitus
  • Able and willing to enroll and meet the requirements of the study
Exclusion Criteria
  • Inability to speak, read or understand English
  • Long-term current use or dependency on insulin
  • Systolic blood pressure >180 mm Hg or diastolic blood pressure >100 mm Hg
  • Resting heart rate > 120 bpm
  • History of or present heart or cardiovascular conditions
  • History of or present respiratory disease
  • History of or present spinal cord injury
  • History of stroke or Transient Ischemic Attack (TIA)
  • History of cancer diagnosis in the past 5 years or present cancer diagnosis
  • Medical, psychiatric, behavioral limitations that may interfere with study participation
  • Participating in other clinical trials that may interfere with study procedures and outcomes
  • Currently pregnant or plans to become pregnant within three years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changes in Hemoglobin A1c Level Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Maximal Oxygen Consumption Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Self-Reported Physical Activity Level Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Secondary Outcome Measures
NameTimeMethod
Changes in Self-Reported Quality of Life Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Body Mass Index Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Blood Pressure Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Heart Rate Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Body Weight Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Waist Circumference Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Exercise Perception Across Study VisitsBaseline, 6-, 30-month follow-up
Changes in Patient Satisfaction During Intervention Period3-, 6-month follow-up
Changes in Dietary Intake Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up

Trial Locations

Locations (1)

Stanford University

🇺🇸

Palo Alto, California, United States

Stanford University
🇺🇸Palo Alto, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.